1,4-dibromobutane

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

28/08/1986 to 16/10/1986

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

guideline study

Justification for type of information:

Data is from study report.

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1986

Report date:

1986

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

OECD Guideline 401 (Acute Oral Toxicity)

Test guideline 2

Qualifier:

according to guideline

Guideline:

other: EWG Directive 84/449/EWG

Principles of method if other than guideline:

Acute oral toxicity study with test chemical in rats.

GLP compliance:

not specified

Test type:

other: No data

Limit test:

no

Test material

Test material information

Constituent 1

Reference substance name:

1,4-dibromobutane

EC Number:

203-775-5

EC Name:

1,4-dibromobutane

Cas Number:

110-52-1

Molecular formula:

C4H8Br2

IUPAC Name:

1,4-dibromobutane

Test material form:

other: liquid

Details on test material:

Name: 1,4-dibromobutane
InChI: 1S/C4H8Br2/c5-3-1-2-4-6/h1-4H2
Smiles: C(CCBr)CBr
- Name of test material (as cited in study report):DIBROMBUTAN - ROH
- Molecular formula (if other than submission substance):C4H8Br2
- Molecular weight (if other than submission substance):215.915 g/mol
- Substance type:Organic
- Physical state:liquid
- Purity: >96 %
- Impurities (identity and concentrations):<1%

Test animals

Species:

rat

Strain:

other: KFM-Han. Wistar

Remarks:

(outbred, SPF-Quality)

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Kleintierfarm Madoerin AG,
CH 4414 Fuellinsdorf / Switzerland
- Age at study initiation: 9 to 13 weeks old
- Weight at study initiation: Animals were weighed as follows - Males: 190 - 263 g; Females: 179 - 222 g
- Fasting period before study: The rats were fasted for 12 to 18 hours.
- Housing: Groups of 5 in Makrolon type-3 cages with standard softwood bedding
- Diet (e.g. ad libitum): Pelleted standard Kuba 343, Batch 50/86 rat maintenance diet, ad libitum.
- Water (e.g. ad libitum): Community tap water from Itingen, ad libitum.
- Acclimation period: At least one week under laboratory conditions, after veterinary examination.
ENVIRONMENTAL CONDITIONS
- Temperature (°C):22±3°C
- Humidity (%):relative humidity 40-70 %
- Air changes (per hr): Air-conditioned with 10-15 air changes per hour.
- Photoperiod (hrs dark / hrs light): 12 hours artificial fluorescent light/12 hours dark, music/light period.
IN-LIFE DATES: From: August 21, 1986 To: October 16, 1986

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

CMC (carboxymethyl cellulose)

Remarks:

4 % solution of CMC carboxymethylcellulose sodium salt in distilled water

Details on oral exposure:

VEHICLE
- Concentration in vehicle: Group 1: 10 ml at 100 mg/kg; Group 2: 10 ml at 400 mg/kg;
Group 3: 10 ml at 1000 mg/kg; Group 4: 20 ml at 5000 mg/kg.
DOSAGE PREPARATION (if unusual): The test article was placed into a glass beaker on a tared Mettler PK 4800 balance, and the vehicle (4 % solution of CMC, carboxymethylcellulose sodium salt in distilled water) was added. A weight by volume dilution was prepared using a homogenizer.

Doses:

100, 400, 1000 and 5000 mg/kg

No. of animals per sex per dose:

Total = 40 (sex/dose)

Control animals:

not specified

Details on study design:

- Duration of observation period following administration: 15 days
- Frequency of observations and weighing: Mortality was observed 4 times during test day 1, and daily during days 2-15; and weighing: Test days 1 (pre-administration), 8 and 15 day.
- Necropsy of survivors performed: yes, all animals surviving to the end of the observation period were killed by intraperitoneal injection of sodium pentobarbitone.
- Other examinations performed: Each animal was examined for changes in appearance and behavior 4 times during day 1, and daily during days 2-15. All abnormalities were recorded. The animals were checked for the symptoms like - General Behavior, respiration, body posture, motor susceptibility, motility, etc.

Statistics:

The LOGIT-Model was applied to estimate the toxicity value. Additionally, the 90, 95 and 99% confidence intervals for the toxicity for each sex and the slope of the dose response line were estimated.

Results and discussion

Preliminary study:

No data

Effect levels

Effect levels 1

Sex:

male/female

Dose descriptor:

LD50

Effect level:

473 mg/kg bw

Based on:

test mat.

95% CL:

>= 311 - <= 889

Remarks on result:

other: 50% mortality was observed

Effect levels 2

Sex:

male

Dose descriptor:

LD50

Effect level:

454 mg/kg bw

Based on:

test mat.

95% CL:

>= 227 - <= 1 582

Remarks on result:

other: 50% mortality was observed

Effect levels 3

Sex:

female

Dose descriptor:

LD50

Effect level:

454 mg/kg bw

Based on:

test mat.

95% CL:

>= 227 - <= 1 582

Remarks on result:

other: 50% mortality was observed

Mortality:

Mortality was observed as follows – In males – At 400 mg/kg: 1 animal was died.
At 1000 mg/kg: All animals were died.
At 5000 mg/kg: All animals were died.
In Females – At 400 mg/kg: 1 animal was died. At 1000 mg/kg: All animals were died. At 5000 mg/kg: All animals were died.

Clinical signs:

other: The following symptoms were observed: At 100 mg/kg: sedation, ataxia, curved body position, ruffled fur; At 400 mg/kg: sedation, chromodacryorrhea, ataxia, curved body position, ruffled fur; At 1000 mg/kg: sedation, dyspnea, ataxia, curved body position,

Gross pathology:

The following macroscopic organ changes were observed: At 100 mg/kg: no pathologic changes (10).
At 400 mg/kg: lung - discolored, dark-red (1); thymus - discolored, dark-red (1); stomach - meteorism, totally filled (1); p1eura1 cavity - watery, clear fluid (1ml) (1); skin, abdominal cavity - red to brown, yellowish, partly exfoliation, diameter 7mm (1); cannibalism - whole animal (1); no pathologic changes (8).
At 1000 mg/kg: lung - pale (1); dark-red (7); foam excretion (1); several foci, diameter 2mm (2); liver - dark-red (2); stomach - meteorism (2); intestines - meteorism (1);
no pathologic changes (2).
At 5000 mg/kg: lung - dark-red, black foci (1); reddish (6); right, dark-red foci (1); dark-red (1); liver - black (5); spleen - black (5); stomach - meteorism (1); pleural cavity - watery, clear, fluid, (1ml).

Other findings:

No data

Applicant's summary and conclusion

Interpretation of results:

Category 4 based on GHS criteria

Conclusions:

The LD50 was considered to be 473 mg/kg bw in both Males/Females with a 95 % confidence interval of 311 - 889 mg/kg bw; 454 mg/kg with 95 % confidence interval of 227 - 1582 mg/kg in males; and 454 mg/kg ith 95 % confidence interval of 227 - 1582 mg/kg in females, when KFM-Han. Wistar rats were treated with test chemical via oral gavage route.

Executive summary:

Acute oral toxicity test was conducted according to OECD Guidelines No. 401 “Acute Oral Toxicity" and EWG Directive 84/449/EWG, using test chemical in 40 male and female KFM-Han. Wistar (outbred, SPF-Quality) rats at the concentration of 100, 400, 1000 and 5000 mg/kg bw. The test substance (Purity >96%) was placed into a glass beaker on a tared Mettler PK 4800 balance, and the vehicle (4 % solution of CMC, carboxymethylcellulose sodium salt in distilled water) was added. A weight by volume dilution was prepared using a homogenizer and administered by oral gavage route at the concentration in vehicle as: Group 1: 10 ml at 100 mg/kg; Group 2: 10 ml at 400 mg/kg; Group 3: 10 ml at 1000 mg/kg; Group 4: 20 ml at 5000 mg/kg. Mortality was observed 4 times during test day 1, and daily during days 2-15; and weighing: Test days 1 (pre-administration), 8 and 15 day. All animals surviving to the end of the observation period were killed by intraperitoneal injection of sodium pentobarbitone. Each animal was examined for changes in appearance and behavior 4 times during day 1, and daily during days 2-15. All abnormalities were recorded. The animals were checked for the symptoms like - General Behavior, respiration, body posture, motor susceptibility, motility, etc.The LOGIT-Model was applied to estimate the toxicity value. Additionally, the 90, 95 and 99% confidence intervals for the toxicity for each sex and the slope of the dose response line were estimated.Mortality was observed as - In males – At 400 mg/kg: 1 animal was died. At 1000 mg/kg: All animals were died. At 5000 mg/kg: All animals were died. In Females – At 400 mg/kg: 1 animal was died. At 1000 mg/kg: All animals were died. At 5000 mg/kg: All animals were died. The symptoms were observed in animals as: At 100 mg/kg: sedation, ataxia, curved body position, ruffled fur; At 400 mg/kg: sedation, chromodacryorrhea, ataxia, curved body position, ruffled fur; At 1000 mg/kg: sedation, dyspnea, ataxia, curved body position, ruffled fur; At 5000 mg/kg: sedation, somnolence, rales, chromodacryorrhea, ataxia, latero-abdominal, position, curved body position, ruffled furventral body position (females). All surviving rats had recovered within 4 to 5 observation days. Therefore, LD50 was considered to be 473 mg/kg bw in both Males/Females with a 95 % confidence interval of 311 - 889 mg/kg bw; 454 mg/kg with 95 % confidence interval of 227 - 1582 mg/kg in males; and 454 mg/kg ith 95 % confidence interval of 227 - 1582 mg/kg in females, when KFM-Han. Wistar rats were treated with test chemical via oral gavage route.